ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,184Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 890

$1.53M Total Retail Price of All Prescriptions

Rank: 9 out of 890

680 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 680 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

27% of this provider’s 680 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 21,271 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,122 719 S3 1 3
AMLODIPINE BESYLATE 1,088 842 2 1
PRAVASTATIN SODIUM 905 748 3 10
OMEPRAZOLE 773 594 4 8
FUROSEMIDE 636 519 5 7
LEVOTHYROXINE SODIUM 507 412 6 2
METOPROLOL SUCCINATE 503 372 7 17
METFORMIN HCL 502 383 8 6
CITALOPRAM HBR 501 381 9 20
ENALAPRIL MALEATE 478 355 10 56
WARFARIN SODIUM 436 363 11 24
METOPROLOL TARTRATE 432 333 12 15
HYDROCHLOROTHIAZIDE 411 299 13 9
POTASSIUM CHLORIDE 396 340 14 11
GABAPENTIN 333 205 15 12
RANITIDINE HCL 330 263 16 49
LISINOPRIL 329 206 17 4
CYMBALTA 323 204 18 45
ZOLPIDEM TARTRATE 317 212 19 19
NEXIUM 270 198 20 14
MIRTAZAPINE 259 150 21 82
FENOFIBRATE 257 138 22 74
AZITHROMYCIN 253 189 23 37
POLYETHYLENE GLYCOL 3350 252 191 24 67
SIMVASTATIN 251 230 25 5
CLOPIDOGREL 250 191 26 28
DIGOXIN 247 230 27 65
CARVEDILOL 232 190 28 22
TRAZODONE HCL 227 116 29 40
NAMENDA 220 220 30 36
DIOVAN 220 183 30 33
TAMSULOSIN HCL 220 173 30 32
TRAMADOL HCL 213 163 33 16
ATORVASTATIN CALCIUM 206 165 34 13
SPIRIVA 205 138 35 66
GLIMEPIRIDE 200 137 36 27
PREDNISONE 198 157 37 47
PLAVIX 195 154 38 42
LYRICA 186 112 39 71
AMITRIPTYLINE HCL 181 106 R 40 43
ALENDRONATE SODIUM 179 150 41 38
CARBIDOPA-LEVODOPA 178 146 42 136
RISPERIDONE 170 124 43 78
CYCLOBENZAPRINE HCL 166 92 R 44 64
DOXAZOSIN MESYLATE 166 112 44 70
CRESTOR 166 114 44 25
MELOXICAM 159 105 47 18
QUETIAPINE FUMARATE 159 108 47 73
BENAZEPRIL HCL 151 105 49 44
LEVOTHROID 151 149 49 306
ROPINIROLE HCL 151 126 49 93
SULFAMETHOXAZOLE-TRIMETHOPRIM 149 120 52 76
ENALAPRIL-HYDROCHLOROTHIAZIDE 147 93 53 230
SEROQUEL XR 146 81 54 240
ADVAIR DISKUS 145 116 55 52
LOVASTATIN 143 116 56 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 142 108 57 21
PANTOPRAZOLE SODIUM 137 61 58 34
DOXYCYCLINE HYCLATE 133 97 59 89
CIPROFLOXACIN HCL 132 107 60 58
ALLOPURINOL 132 100 60 31
LOSARTAN POTASSIUM 131 128 62 29
PREMARIN 131 88 R 62 105
NITROFURANTOIN MONO-MACRO 129 113 64 181
FLUTICASONE PROPIONATE 127 95 65 39
TRAMADOL HCL-ACETAMINOPHEN 124 64 66 117
LEVOFLOXACIN 124 80 66 107
SUCRALFATE 124 99 66 158
LOVAZA 123 62 69 120
CARISOPRODOL 120 23 R 70 69
MORPHINE SULFATE ER 117 43 S2 71 207
DONEPEZIL HCL 115 114 72 30
AMLODIPINE BESYLATE-BENAZEPRIL 114 108 73 41
ATENOLOL 113 97 74 23
BUPROPION HCL SR 113 77 74 216
CLONIDINE HCL 113 92 74 35
BUSPIRONE HCL 111 87 77 133
PROAIR HFA 106 60 78 55
PROMETHAZINE HCL 104 54 R 79 104
VENLAFAXINE HCL ER 104 27 79 114
COLCRYS 102 83 81 150
MUPIROCIN 101 82 82 121
LANTUS 100 42 83 50
EXELON 99 86 84 113
PAROXETINE HCL 97 44 85 68
CEPHALEXIN 96 71 86 119
DIOVAN HCT 95 67 87 48
ESCITALOPRAM OXALATE 89 52 88 51
METOCLOPRAMIDE HCL 88 85 89 125
JANUVIA 88 76 89 59
MECLIZINE HCL 88 77 89 97
NOVOLIN R 87 55 92 153
FENTANYL 85 62 S2 93 151
CARAFATE 81 63 94 261
AMOXICILLIN 78 55 95 94
TRICOR 77 56 96 98
OXYCODONE HCL-ACETAMINOPHEN 75 29 S2 97 127
KLOR-CON M20 75 59 97 72
METHADONE HCL 73 12 S2 99 157
FEXOFENADINE HCL 73 53 99 272
SERTRALINE HCL 72 68 101 26
FINASTERIDE 71 67 102 108
HYDROXYZINE PAMOATE 71 70 R 102 205
SINGULAIR 70 58 104 79
VESICARE 68 65 105 188
ISOSORBIDE MONONITRATE ER 68 36 105 60
LACTULOSE 68 28 105 112
ENABLEX 67 66 108 248
INSULIN SYRINGE 67 33 108 99
FLUOXETINE HCL 65 28 110 63
LOSARTAN-HYDROCHLOROTHIAZIDE 65 44 110 57
LIPITOR 64 40 112 77
FAMOTIDINE 63 59 113 90
SEROQUEL 63 41 113 167
FLUCONAZOLE 62 37 115 155
SYMBICORT 60 29 116 174
CLOTRIMAZOLE-BETAMETHASONE 59 40 117 152
AZELASTINE HCL 58 50 118 293
CELEBREX 58 37 118 91
GLIPIZIDE 57 53 120 62
MONTELUKAST SODIUM 56 45 121 130
GLYBURIDE 56 56 R 121 83
HUMULIN 70-30 56 26 121 241
NIASPAN 55 27 124 212
ENDOCET 55 48 S2 124 218
BENZTROPINE MESYLATE 53 0 R 126 196
ESTRADIOL 53 42 R 126 118
PRENATAL PLUS 53 52 126 318
FOSINOPRIL SODIUM 53 37 126 184
PHENYTOIN SODIUM EXTENDED 52 20 130 111
METHYLPREDNISOLONE 52 36 130 109
VENTOLIN HFA 51 26 132 177
NAPROXEN 51 25 132 84
RIVASTIGMINE 51 51 132 314
AMOX TR-POTASSIUM CLAVULANATE 50 30 135 132
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 2, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.